Octant

A synthetic biology drug discovery company that maps receptor pathway activity at scale to design multi-target small molecules for complex diseases.

Location: Emeryville, CA, USA

1 model

Models (1)

OpenADMET / Open Molecular Software Foundation / Octant / UCSF

Released December 9, 2025

———

ADMET property prediction for CYP inhibition, PXR activation, hERG, microsomal clearance, and permeability, all trained on public assay data.

Small molecule